Rinvoq 00074-2320-01
Generic: Upadacitinib
- Manufacturer
- Abbvie Inc.
- Dosage Form
- Solution
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 26, 2024
- Listing Expires
- December 31, 2027
- Application
- NDA218347
Need to source Rinvoq? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Upadacitinib | 1 mg/mL |
Drug Class
Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitors [MoA]
Selected Package
00074-2320-01Selected1 BOTTLE in 1 CARTON (0074-2320-01) / 180 mL in 1 BOTTLE
Other packages for this product(1)
1 BOTTLE in 1 CARTON (0074-2320-70) / 180 mL in 1 BOTTLE